Trajectories of responses to mepolizumab in severe asthma.

Eur Respir J

Research Institute of St. Joe's, St Joseph's Healthcare, Hamilton, Hamilton, ON, Canada.

Published: January 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02023-2024DOI Listing

Publication Analysis

Top Keywords

trajectories responses
4
responses mepolizumab
4
mepolizumab severe
4
severe asthma
4
trajectories
1
mepolizumab
1
severe
1
asthma
1

Similar Publications

[Behavioral problems in child protection: Understanding and intervening from the concept of complex trauma].

Encephale

September 2025

Laboratoire INTERPSY, université de Lorraine, Nancy, France; Hôpitaux de Saint-Maurice, Saint-Maurice, France. Electronic address:

Introduction: Adolescents supported by child protection services (CPS) represent a population exposed to repeated relational trauma that significantly increases the risk of developing complex trauma characterized by polymorphic symptomatology. The behavioral problems presented by adolescents followed by CPS may fit within this nosographic framework. They can lead to major difficulties in adapting to their environment, especially when the trajectory of polyvictimization is pronounced.

View Article and Find Full Text PDF

Design of a modified model predictive control and composite control strategy for hydraulic turbine regulation system.

ISA Trans

August 2025

Engineering Research Center for Metallurgical Automation and Measurement Technology of Ministry of Education, Wuhan 430081, China; Institute of Robotics and Intelligent Systems, Wuhan University of Science and Technology, Wuhan 430081, China; School of Artifitial Intelligence and Automation, Wuhan U

As a critical component in hydropower systems, the Hydraulic Turbine Regulation System (HTRS) exhibits strong coupling characteristics that impose substantial challenges on control system design, necessitating the development of high-performance control strategies. To address the complex control requirements, this paper proposes an improved T-S fuzzy modeling method based on the Luenberger observer theory. It constructs a system model that combines high accuracy and simplicity.

View Article and Find Full Text PDF

Despite growing recognition of health as a multidimensional construct, few studies have examined how physical, psychological, and behavioral health dimensions coalesce and evolve across the transition from young to middle adulthood, especially within the context of life-course adversities. Existing research often focuses on isolated health indicators or overlooks the dynamic, fluid nature of health over time. Additionally, the combined effects of childhood and adulthood adversities on health transitions remain underexplored.

View Article and Find Full Text PDF

The influence of metabolic dysfunction on depressive symptom trajectories: A one-year follow-up study.

J Affect Disord

September 2025

Département de psychiatrie et d'addictologie, Université de Montréal, Montréal, Québec, Canada; Centre de recherche de l'Institut universitaire en santé mentale (CR-IUSMM), Université de Montréal, Montréal, Québec, Canada.

This study explored the role of metabolic syndrome (MetS) and health-related behaviors in the progression of depressive symptoms over a one-year naturalistic follow-up in patients with depressive disorder. Using data from 153 participants recruited through the Signature Biobank at a psychiatric emergency setting, we tested whether MetS mediated the relationship between health-related behaviors such as smoking, alcohol and drug use, and sleep, and depressive symptom trajectories. Linear mixed models revealed that while depressive symptoms significantly decreased over time, higher MetS score was associated with a slower improvement in depressive symptoms.

View Article and Find Full Text PDF

Moraxella catarrhalis is a Gram-negative diplococcus bacterium and a common respiratory pathogen, implicated in 15-20% of otitis media (OM) cases in children and chronic obstructive pulmonary disease (COPD) in adults. The rise of drug-resistant Moraxella catarrhalis has highlighted the urgent need for the potent vaccine strategies to reduce its clinical burden. Despite a mortality rate of 13%, there is no FDA-approved vaccine for this pathogen.

View Article and Find Full Text PDF